Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Krishna Nalleballe to Antibodies, Monoclonal, Humanized

This is a "connection" page, showing publications Krishna Nalleballe has written about Antibodies, Monoclonal, Humanized.

 
Connection Strength
  
 
 
0.039
  
  1. Stone RL, Sood AK, Coleman RL. Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer. Lancet Oncol. 2010 May; 11(5):465-75.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.